Chengdu Easton Biopharmaceuticals (688513.SH) announced that the company's deputy general manager and core technical staff HONG CHEN...
According to an announcement by Chengdu Easton Biopharmaceuticals (688513.SH), the company's deputy general manager and core technical staff HONG CHEN has reached the statutory retirement age and resigned from the position for personal reasons, no longer holding any position in the company.
On June 28, 2024, the Board of Directors' 20th meeting of the third session of Chengdu Easton Biopharmaceuticals approved the proposal of "adding recognized core technical staff", recognizing LIZHUSHI as the company's core technical staff.